Login / Signup

Duration of antibiotic therapy in non-cystic fibrosis bronchiectasis.

R SomayajiC H Goss
Published in: Current pulmonology reports (2019)
c)There is a paucity of evidence for optimal antibiotic strategies in exacerbations and chronic maintenance in persons with non-cystic fibrosis bronchiectasis. Rationally designed studies which utilize a registry and population-based approach will be critical to build evidence-based strategies to optimize management of non-cystic fibrosis bronchiectasis.
Keyphrases
  • cystic fibrosis
  • pseudomonas aeruginosa
  • lung function
  • chronic obstructive pulmonary disease
  • bone marrow
  • case control
  • mesenchymal stem cells
  • air pollution
  • cell therapy
  • replacement therapy
  • smoking cessation